Report Overview
This report provides a deep insight into the global Novel Coronavirus (COVID-19) Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Novel Coronavirus (COVID-19) Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Novel Coronavirus (COVID-19) Vaccine market in any manner.
Global Novel Coronavirus (COVID-19) Vaccine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Inovio Pharmaceuticals
Takis Biotech (Evvivax)
Zydus Cadila
Codagenix, Inc.
GeoVax, Inc.
Bravovax
Janssen Pharmaceutical Companies
Altimmune
Vaxart
CanSino Biologics
ExpreS2ion Biotechnologies ApS
Clover Biopharmaceuticals
GSK
Vaxil Bio Ltd.
Generex
Novavax, Inc.
Sanofi Pasteur
Baylor
iBio, Inc.
Moderna, Inc.
Curevac
ImmunoPrecise
Market Segmentation (by Type)
DNA
RNA
Others
Market Segmentation (by Application)
Mild Symptom Patient
Critically Ill Patient
Geographic Segmentation
? North America (USA, Canada, Mexico)
? Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
? Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
? South America (Brazil, Argentina, Columbia, Rest of South America)
? The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
? Industry drivers, restraints, and opportunities covered in the study
? Neutral perspective on the market performance
? Recent industry trends and developments
? Competitive landscape & strategies of key players
? Potential & niche segments and regions exhibiting promising growth covered
? Historical, current, and projected market size, in terms of value
? In-depth analysis of the Novel Coronavirus (COVID-19) Vaccine Market
? Overview of the regional outlook of the Novel Coronavirus (COVID-19) Vaccine Market:
Key Reasons to Buy this Report:
? Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
? This enables you to anticipate market changes to remain ahead of your competitors
? You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
? The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
? Provision of market value (USD Billion) data for each segment and sub-segment
? Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
? Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
? Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
? Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
? The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
? Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
? Provides insight into the market through Value Chain
? Market dynamics scenario, along with growth opportunities of the market in the years to come
? 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Novel Coronavirus (COVID-19) Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Novel Coronavirus (COVID-19) Vaccine
1.2 Key Market Segments
1.2.1 Novel Coronavirus (COVID-19) Vaccine Segment by Type
1.2.2 Novel Coronavirus (COVID-19) Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Novel Coronavirus (COVID-19) Vaccine Market Overview
2.1 Global Market Overview
2.1.1 Global Novel Coronavirus (COVID-19) Vaccine Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Novel Coronavirus (COVID-19) Vaccine Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Novel Coronavirus (COVID-19) Vaccine Market Competitive Landscape
3.1 Global Novel Coronavirus (COVID-19) Vaccine Sales by Manufacturers (2019-2024)
3.2 Global Novel Coronavirus (COVID-19) Vaccine Revenue Market Share by Manufacturers (2019-2024)
3.3 Novel Coronavirus (COVID-19) Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Novel Coronavirus (COVID-19) Vaccine Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Novel Coronavirus (COVID-19) Vaccine Sales Sites, Area Served, Product Type
3.6 Novel Coronavirus (COVID-19) Vaccine Market Competitive Situation and Trends
3.6.1 Novel Coronavirus (COVID-19) Vaccine Market Concentration Rate
3.6.2 Global 5 and 10 Largest Novel Coronavirus (COVID-19) Vaccine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Novel Coronavirus (COVID-19) Vaccine Industry Chain Analysis
4.1 Novel Coronavirus (COVID-19) Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Novel Coronavirus (COVID-19) Vaccine Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Novel Coronavirus (COVID-19) Vaccine Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Novel Coronavirus (COVID-19) Vaccine Sales Market Share by Type (2019-2024)
6.3 Global Novel Coronavirus (COVID-19) Vaccine Market Size Market Share by Type (2019-2024)
6.4 Global Novel Coronavirus (COVID-19) Vaccine Price by Type (2019-2024)
7 Novel Coronavirus (COVID-19) Vaccine Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Novel Coronavirus (COVID-19) Vaccine Market Sales by Application (2019-2024)
7.3 Global Novel Coronavirus (COVID-19) Vaccine Market Size (M USD) by Application (2019-2024)
7.4 Global Novel Coronavirus (COVID-19) Vaccine Sales Growth Rate by Application (2019-2024)
8 Novel Coronavirus (COVID-19) Vaccine Market Segmentation by Region
8.1 Global Novel Coronavirus (COVID-19) Vaccine Sales by Region
8.1.1 Global Novel Coronavirus (COVID-19) Vaccine Sales by Region
8.1.2 Global Novel Coronavirus (COVID-19) Vaccine Sales Market Share by Region
8.2 North America
8.2.1 North America Novel Coronavirus (COVID-19) Vaccine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Novel Coronavirus (COVID-19) Vaccine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Novel Coronavirus (COVID-19) Vaccine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Novel Coronavirus (COVID-19) Vaccine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Novel Coronavirus (COVID-19) Vaccine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Inovio Pharmaceuticals
9.1.1 Inovio Pharmaceuticals Novel Coronavirus (COVID-19) Vaccine Basic Information
9.1.2 Inovio Pharmaceuticals Novel Coronavirus (COVID-19) Vaccine Product Overview
9.1.3 Inovio Pharmaceuticals Novel Coronavirus (COVID-19) Vaccine Product Market Performance
9.1.4 Inovio Pharmaceuticals Business Overview
9.1.5 Inovio Pharmaceuticals Novel Coronavirus (COVID-19) Vaccine SWOT Analysis
9.1.6 Inovio Pharmaceuticals Recent Developments
9.2 Takis Biotech (Evvivax)
9.2.1 Takis Biotech (Evvivax) Novel Coronavirus (COVID-19) Vaccine Basic Information
9.2.2 Takis Biotech (Evvivax) Novel Coronavirus (COVID-19) Vaccine Product Overview
9.2.3 Takis Biotech (Evvivax) Novel Coronavirus (COVID-19) Vaccine Product Market Performance
9.2.4 Takis Biotech (Evvivax) Business Overview
9.2.5 Takis Biotech (Evvivax) Novel Coronavirus (COVID-19) Vaccine SWOT Analysis
9.2.6 Takis Biotech (Evvivax) Recent Developments
9.3 Zydus Cadila
9.3.1 Zydus Cadila Novel Coronavirus (COVID-19) Vaccine Basic Information
9.3.2 Zydus Cadila Novel Coronavirus (COVID-19) Vaccine Product Overview
9.3.3 Zydus Cadila Novel Coronavirus (COVID-19) Vaccine Product Market Performance
9.3.4 Zydus Cadila Novel Coronavirus (COVID-19) Vaccine SWOT Analysis
9.3.5 Zydus Cadila Business Overview
9.3.6 Zydus Cadila Recent Developments
9.4 Codagenix, Inc.
9.4.1 Codagenix, Inc. Novel Coronavirus (COVID-19) Vaccine Basic Information
9.4.2 Codagenix, Inc. Novel Coronavirus (COVID-19) Vaccine Product Overview
9.4.3 Codagenix, Inc. Novel Coronavirus (COVID-19) Vaccine Product Market Performance
9.4.4 Codagenix, Inc. Business Overview
9.4.5 Codagenix, Inc. Recent Developments
9.5 GeoVax, Inc.
9.5.1 GeoVax, Inc. Novel Coronavirus (COVID-19) Vaccine Basic Information
9.5.2 GeoVax, Inc. Novel Coronavirus (COVID-19) Vaccine Product Overview
9.5.3 GeoVax, Inc. Novel Coronavirus (COVID-19) Vaccine Product Market Performance
9.5.4 GeoVax, Inc. Business Overview
9.5.5 GeoVax, Inc. Recent Developments
9.6 Bravovax
9.6.1 Bravovax Novel Coronavirus (COVID-19) Vaccine Basic Information
9.6.2 Bravovax Novel Coronavirus (COVID-19) Vaccine Product Overview
9.6.3 Bravovax Novel Coronavirus (COVID-19) Vaccine Product Market Performance
9.6.4 Bravovax Business Overview
9.6.5 Bravovax Recent Developments
9.7 Janssen Pharmaceutical Companies
9.7.1 Janssen Pharmaceutical Companies Novel Coronavirus (COVID-19) Vaccine Basic Information
9.7.2 Janssen Pharmaceutical Companies Novel Coronavirus (COVID-19) Vaccine Product Overview
9.7.3 Janssen Pharmaceutical Companies Novel Coronavirus (COVID-19) Vaccine Product Market Performance
9.7.4 Janssen Pharmaceutical Companies Business Overview
9.7.5 Janssen Pharmaceutical Companies Recent Developments
9.8 Altimmune
9.8.1 Altimmune Novel Coronavirus (COVID-19) Vaccine Basic Information
9.8.2 Altimmune Novel Coronavirus (COVID-19) Vaccine Product Overview
9.8.3 Altimmune Novel Coronavirus (COVID-19) Vaccine Product Market Performance
9.8.4 Altimmune Business Overview
9.8.5 Altimmune Recent Developments
9.9 Vaxart
9.9.1 Vaxart Novel Coronavirus (COVID-19) Vaccine Basic Information
9.9.2 Vaxart Novel Coronavirus (COVID-19) Vaccine Product Overview
9.9.3 Vaxart Novel Coronavirus (COVID-19) Vaccine Product Market Performance
9.9.4 Vaxart Business Overview
9.9.5 Vaxart Recent Developments
9.10 CanSino Biologics
9.10.1 CanSino Biologics Novel Coronavirus (COVID-19) Vaccine Basic Information
9.10.2 CanSino Biologics Novel Coronavirus (COVID-19) Vaccine Product Overview
9.10.3 CanSino Biologics Novel Coronavirus (COVID-19) Vaccine Product Market Performance
9.10.4 CanSino Biologics Business Overview
9.10.5 CanSino Biologics Recent Developments
9.11 ExpreS2ion Biotechnologies ApS
9.11.1 ExpreS2ion Biotechnologies ApS Novel Coronavirus (COVID-19) Vaccine Basic Information
9.11.2 ExpreS2ion Biotechnologies ApS Novel Coronavirus (COVID-19) Vaccine Product Overview
9.11.3 ExpreS2ion Biotechnologies ApS Novel Coronavirus (COVID-19) Vaccine Product Market Performance
9.11.4 ExpreS2ion Biotechnologies ApS Business Overview
9.11.5 ExpreS2ion Biotechnologies ApS Recent Developments
9.12 Clover Biopharmaceuticals
9.12.1 Clover Biopharmaceuticals Novel Coronavirus (COVID-19) Vaccine Basic Information
9.12.2 Clover Biopharmaceuticals Novel Coronavirus (COVID-19) Vaccine Product Overview
9.12.3 Clover Biopharmaceuticals Novel Coronavirus (COVID-19) Vaccine Product Market Performance
9.12.4 Clover Biopharmaceuticals Business Overview
9.12.5 Clover Biopharmaceuticals Recent Developments
9.13 GSK
9.13.1 GSK Novel Coronavirus (COVID-19) Vaccine Basic Information
9.13.2 GSK Novel Coronavirus (COVID-19) Vaccine Product Overview
9.13.3 GSK Novel Coronavirus (COVID-19) Vaccine Product Market Performance
9.13.4 GSK Business Overview
9.13.5 GSK Recent Developments
9.14 Vaxil Bio Ltd.
9.14.1 Vaxil Bio Ltd. Novel Coronavirus (COVID-19) Vaccine Basic Information
9.14.2 Vaxil Bio Ltd. Novel Coronavirus (COVID-19) Vaccine Product Overview
9.14.3 Vaxil Bio Ltd. Novel Coronavirus (COVID-19) Vaccine Product Market Performance
9.14.4 Vaxil Bio Ltd. Business Overview
9.14.5 Vaxil Bio Ltd. Recent Developments
9.15 Generex
9.15.1 Generex Novel Coronavirus (COVID-19) Vaccine Basic Information
9.15.2 Generex Novel Coronavirus (COVID-19) Vaccine Product Overview
9.15.3 Generex Novel Coronavirus (COVID-19) Vaccine Product Market Performance
9.15.4 Generex Business Overview
9.15.5 Generex Recent Developments
9.16 Novavax, Inc.
9.16.1 Novavax, Inc. Novel Coronavirus (COVID-19) Vaccine Basic Information
9.16.2 Novavax, Inc. Novel Coronavirus (COVID-19) Vaccine Product Overview
9.16.3 Novavax, Inc. Novel Coronavirus (COVID-19) Vaccine Product Market Performance
9.16.4 Novavax, Inc. Business Overview
9.16.5 Novavax, Inc. Recent Developments
9.17 Sanofi Pasteur
9.17.1 Sanofi Pasteur Novel Coronavirus (COVID-19) Vaccine Basic Information
9.17.2 Sanofi Pasteur Novel Coronavirus (COVID-19) Vaccine Product Overview
9.17.3 Sanofi Pasteur Novel Coronavirus (COVID-19) Vaccine Product Market Performance
9.17.4 Sanofi Pasteur Business Overview
9.17.5 Sanofi Pasteur Recent Developments
9.18 Baylor
9.18.1 Baylor Novel Coronavirus (COVID-19) Vaccine Basic Information
9.18.2 Baylor Novel Coronavirus (COVID-19) Vaccine Product Overview
9.18.3 Baylor Novel Coronavirus (COVID-19) Vaccine Product Market Performance
9.18.4 Baylor Business Overview
9.18.5 Baylor Recent Developments
9.19 iBio, Inc.
9.19.1 iBio, Inc. Novel Coronavirus (COVID-19) Vaccine Basic Information
9.19.2 iBio, Inc. Novel Coronavirus (COVID-19) Vaccine Product Overview
9.19.3 iBio, Inc. Novel Coronavirus (COVID-19) Vaccine Product Market Performance
9.19.4 iBio, Inc. Business Overview
9.19.5 iBio, Inc. Recent Developments
9.20 Moderna, Inc.
9.20.1 Moderna, Inc. Novel Coronavirus (COVID-19) Vaccine Basic Information
9.20.2 Moderna, Inc. Novel Coronavirus (COVID-19) Vaccine Product Overview
9.20.3 Moderna, Inc. Novel Coronavirus (COVID-19) Vaccine Product Market Performance
9.20.4 Moderna, Inc. Business Overview
9.20.5 Moderna, Inc. Recent Developments
9.21 Curevac
9.21.1 Curevac Novel Coronavirus (COVID-19) Vaccine Basic Information
9.21.2 Curevac Novel Coronavirus (COVID-19) Vaccine Product Overview
9.21.3 Curevac Novel Coronavirus (COVID-19) Vaccine Product Market Performance
9.21.4 Curevac Business Overview
9.21.5 Curevac Recent Developments
9.22 ImmunoPrecise
9.22.1 ImmunoPrecise Novel Coronavirus (COVID-19) Vaccine Basic Information
9.22.2 ImmunoPrecise Novel Coronavirus (COVID-19) Vaccine Product Overview
9.22.3 ImmunoPrecise Novel Coronavirus (COVID-19) Vaccine Product Market Performance
9.22.4 ImmunoPrecise Business Overview
9.22.5 ImmunoPrecise Recent Developments
10 Novel Coronavirus (COVID-19) Vaccine Market Forecast by Region
10.1 Global Novel Coronavirus (COVID-19) Vaccine Market Size Forecast
10.2 Global Novel Coronavirus (COVID-19) Vaccine Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Novel Coronavirus (COVID-19) Vaccine Market Size Forecast by Country
10.2.3 Asia Pacific Novel Coronavirus (COVID-19) Vaccine Market Size Forecast by Region
10.2.4 South America Novel Coronavirus (COVID-19) Vaccine Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Novel Coronavirus (COVID-19) Vaccine by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Novel Coronavirus (COVID-19) Vaccine Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Novel Coronavirus (COVID-19) Vaccine by Type (2025-2030)
11.1.2 Global Novel Coronavirus (COVID-19) Vaccine Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Novel Coronavirus (COVID-19) Vaccine by Type (2025-2030)
11.2 Global Novel Coronavirus (COVID-19) Vaccine Market Forecast by Application (2025-2030)
11.2.1 Global Novel Coronavirus (COVID-19) Vaccine Sales (K Units) Forecast by Application
11.2.2 Global Novel Coronavirus (COVID-19) Vaccine Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Novel Coronavirus (COVID-19) Vaccine Market Size Comparison by Region (M USD)
Table 5. Global Novel Coronavirus (COVID-19) Vaccine Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Novel Coronavirus (COVID-19) Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Novel Coronavirus (COVID-19) Vaccine Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Novel Coronavirus (COVID-19) Vaccine Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Novel Coronavirus (COVID-19) Vaccine as of 2022)
Table 10. Global Market Novel Coronavirus (COVID-19) Vaccine Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Novel Coronavirus (COVID-19) Vaccine Sales Sites and Area Served
Table 12. Manufacturers Novel Coronavirus (COVID-19) Vaccine Product Type
Table 13. Global Novel Coronavirus (COVID-19) Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Novel Coronavirus (COVID-19) Vaccine
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Novel Coronavirus (COVID-19) Vaccine Market Challenges
Table 22. Global Novel Coronavirus (COVID-19) Vaccine Sales by Type (K Units)
Table 23. Global Novel Coronavirus (COVID-19) Vaccine Market Size by Type (M USD)
Table 24. Global Novel Coronavirus (COVID-19) Vaccine Sales (K Units) by Type (2019-2024)
Table 25. Global Novel Coronavirus (COVID-19) Vaccine Sales Market Share by Type (2019-2024)
Table 26. Global Novel Coronavirus (COVID-19) Vaccine Market Size (M USD) by Type (2019-2024)
Table 27. Global Novel Coronavirus (COVID-19) Vaccine Market Size Share by Type (2019-2024)
Table 28. Global Novel Coronavirus (COVID-19) Vaccine Price (USD/Unit) by Type (2019-2024)
Table 29. Global Novel Coronavirus (COVID-19) Vaccine Sales (K Units) by Application
Table 30. Global Novel Coronavirus (COVID-19) Vaccine Market Size by Application
Table 31. Global Novel Coronavirus (COVID-19) Vaccine Sales by Application (2019-2024) & (K Units)
Table 32. Global Novel Coronavirus (COVID-19) Vaccine Sales Market Share by Application (2019-2024)
Table 33. Global Novel Coronavirus (COVID-19) Vaccine Sales by Application (2019-2024) & (M USD)
Table 34. Global Novel Coronavirus (COVID-19) Vaccine Market Share by Application (2019-2024)
Table 35. Global Novel Coronavirus (COVID-19) Vaccine Sales Growth Rate by Application (2019-2024)
Table 36. Global Novel Coronavirus (COVID-19) Vaccine Sales by Region (2019-2024) & (K Units)
Table 37. Global Novel Coronavirus (COVID-19) Vaccine Sales Market Share by Region (2019-2024)
Table 38. North America Novel Coronavirus (COVID-19) Vaccine Sales by Country (2019-2024) & (K Units)
Table 39. Europe Novel Coronavirus (COVID-19) Vaccine Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Novel Coronavirus (COVID-19) Vaccine Sales by Region (2019-2024) & (K Units)
Table 41. South America Novel Coronavirus (COVID-19) Vaccine Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Novel Coronavirus (COVID-19) Vaccine Sales by Region (2019-2024) & (K Units)
Table 43. Inovio Pharmaceuticals Novel Coronavirus (COVID-19) Vaccine Basic Information
Table 44. Inovio Pharmaceuticals Novel Coronavirus (COVID-19) Vaccine Product Overview
Table 45. Inovio Pharmaceuticals Novel Coronavirus (COVID-19) Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Inovio Pharmaceuticals Business Overview
Table 47. Inovio Pharmaceuticals Novel Coronavirus (COVID-19) Vaccine SWOT Analysis
Table 48. Inovio Pharmaceuticals Recent Developments
Table 49. Takis Biotech (Evvivax) Novel Coronavirus (COVID-19) Vaccine Basic Information
Table 50. Takis Biotech (Evvivax) Novel Coronavirus (COVID-19) Vaccine Product Overview
Table 51. Takis Biotech (Evvivax) Novel Coronavirus (COVID-19) Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Takis Biotech (Evvivax) Business Overview
Table 53. Takis Biotech (Evvivax) Novel Coronavirus (COVID-19) Vaccine SWOT Analysis
Table 54. Takis Biotech (Evvivax) Recent Developments
Table 55. Zydus Cadila Novel Coronavirus (COVID-19) Vaccine Basic Information
Table 56. Zydus Cadila Novel Coronavirus (COVID-19) Vaccine Product Overview
Table 57. Zydus Cadila Novel Coronavirus (COVID-19) Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Zydus Cadila Novel Coronavirus (COVID-19) Vaccine SWOT Analysis
Table 59. Zydus Cadila Business Overview
Table 60. Zydus Cadila Recent Developments
Table 61. Codagenix, Inc. Novel Coronavirus (COVID-19) Vaccine Basic Information
Table 62. Codagenix, Inc. Novel Coronavirus (COVID-19) Vaccine Product Overview
Table 63. Codagenix, Inc. Novel Coronavirus (COVID-19) Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Codagenix, Inc. Business Overview
Table 65. Codagenix, Inc. Recent Developments
Table 66. GeoVax, Inc. Novel Coronavirus (COVID-19) Vaccine Basic Information
Table 67. GeoVax, Inc. Novel Coronavirus (COVID-19) Vaccine Product Overview
Table 68. GeoVax, Inc. Novel Coronavirus (COVID-19) Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. GeoVax, Inc. Business Overview
Table 70. GeoVax, Inc. Recent Developments
Table 71. Bravovax Novel Coronavirus (COVID-19) Vaccine Basic Information
Table 72. Bravovax Novel Coronavirus (COVID-19) Vaccine Product Overview
Table 73. Bravovax Novel Coronavirus (COVID-19) Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Bravovax Business Overview
Table 75. Bravovax Recent Developments
Table 76. Janssen Pharmaceutical Companies Novel Coronavirus (COVID-19) Vaccine Basic Information
Table 77. Janssen Pharmaceutical Companies Novel Coronavirus (COVID-19) Vaccine Product Overview
Table 78. Janssen Pharmaceutical Companies Novel Coronavirus (COVID-19) Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Janssen Pharmaceutical Companies Business Overview
Table 80. Janssen Pharmaceutical Companies Recent Developments
Table 81. Altimmune Novel Coronavirus (COVID-19) Vaccine Basic Information
Table 82. Altimmune Novel Coronavirus (COVID-19) Vaccine Product Overview
Table 83. Altimmune Novel Coronavirus (COVID-19) Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Altimmune Business Overview
Table 85. Altimmune Recent Developments
Table 86. Vaxart Novel Coronavirus (COVID-19) Vaccine Basic Information
Table 87. Vaxart Novel Coronavirus (COVID-19) Vaccine Product Overview
Table 88. Vaxart Novel Coronavirus (COVID-19) Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Vaxart Business Overview
Table 90. Vaxart Recent Developments
Table 91. CanSino Biologics Novel Coronavirus (COVID-19) Vaccine Basic Information
Table 92. CanSino Biologics Novel Coronavirus (COVID-19) Vaccine Product Overview
Table 93. CanSino Biologics Novel Coronavirus (COVID-19) Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. CanSino Biologics Business Overview
Table 95. CanSino Biologics Recent Developments
Table 96. ExpreS2ion Biotechnologies ApS Novel Coronavirus (COVID-19) Vaccine Basic Information
Table 97. ExpreS2ion Biotechnologies ApS Novel Coronavirus (COVID-19) Vaccine Product Overview
Table 98. ExpreS2ion Biotechnologies ApS Novel Coronavirus (COVID-19) Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. ExpreS2ion Biotechnologies ApS Business Overview
Table 100. ExpreS2ion Biotechnologies ApS Recent Developments
Table 101. Clover Biopharmaceuticals Novel Coronavirus (COVID-19) Vaccine Basic Information
Table 102. Clover Biopharmaceuticals Novel Coronavirus (COVID-19) Vaccine Product Overview
Table 103. Clover Biopharmaceuticals Novel Coronavirus (COVID-19) Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Clover Biopharmaceuticals Business Overview
Table 105. Clover Biopharmaceuticals Recent Developments
Table 106. GSK Novel Coronavirus (COVID-19) Vaccine Basic Information
Table 107. GSK Novel Coronavirus (COVID-19) Vaccine Product Overview
Table 108. GSK Novel Coronavirus (COVID-19) Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. GSK Business Overview
Table 110. GSK Recent Developments
Table 111. Vaxil Bio Ltd. Novel Coronavirus (COVID-19) Vaccine Basic Information
Table 112. Vaxil Bio Ltd. Novel Coronavirus (COVID-19) Vaccine Product Overview
Table 113. Vaxil Bio Ltd. Novel Coronavirus (COVID-19) Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Vaxil Bio Ltd. Business Overview
Table 115. Vaxil Bio Ltd. Recent Developments
Table 116. Generex Novel Coronavirus (COVID-19) Vaccine Basic Information
Table 117. Generex Novel Coronavirus (COVID-19) Vaccine Product Overview
Table 118. Generex Novel Coronavirus (COVID-19) Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Generex Business Overview
Table 120. Generex Recent Developments
Table 121. Novavax, Inc. Novel Coronavirus (COVID-19) Vaccine Basic Information
Table 122. Novavax, Inc. Novel Coronavirus (COVID-19) Vaccine Product Overview
Table 123. Novavax, Inc. Novel Coronavirus (COVID-19) Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. Novavax, Inc. Business Overview
Table 125. Novavax, Inc. Recent Developments
Table 126. Sanofi Pasteur Novel Coronavirus (COVID-19) Vaccine Basic Information
Table 127. Sanofi Pasteur Novel Coronavirus (COVID-19) Vaccine Product Overview
Table 128. Sanofi Pasteur Novel Coronavirus (COVID-19) Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. Sanofi Pasteur Business Overview
Table 130. Sanofi Pasteur Recent Developments
Table 131. Baylor Novel Coronavirus (COVID-19) Vaccine Basic Information
Table 132. Baylor Novel Coronavirus (COVID-19) Vaccine Product Overview
Table 133. Baylor Novel Coronavirus (COVID-19) Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 134. Baylor Business Overview
Table 135. Baylor Recent Developments
Table 136. iBio, Inc. Novel Coronavirus (COVID-19) Vaccine Basic Information
Table 137. iBio, Inc. Novel Coronavirus (COVID-19) Vaccine Product Overview
Table 138. iBio, Inc. Novel Coronavirus (COVID-19) Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 139. iBio, Inc. Business Overview
Table 140. iBio, Inc. Recent Developments
Table 141. Moderna, Inc. Novel Coronavirus (COVID-19) Vaccine Basic Information
Table 142. Moderna, Inc. Novel Coronavirus (COVID-19) Vaccine Product Overview
Table 143. Moderna, Inc. Novel Coronavirus (COVID-19) Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 144. Moderna, Inc. Business Overview
Table 145. Moderna, Inc. Recent Developments
Table 146. Curevac Novel Coronavirus (COVID-19) Vaccine Basic Information
Table 147. Curevac Novel Coronavirus (COVID-19) Vaccine Product Overview
Table 148. Curevac Novel Coronavirus (COVID-19) Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 149. Curevac Business Overview
Table 150. Curevac Recent Developments
Table 151. ImmunoPrecise Novel Coronavirus (COVID-19) Vaccine Basic Information
Table 152. ImmunoPrecise Novel Coronavirus (COVID-19) Vaccine Product Overview
Table 153. ImmunoPrecise Novel Coronavirus (COVID-19) Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 154. ImmunoPrecise Business Overview
Table 155. ImmunoPrecise Recent Developments
Table 156. Global Novel Coronavirus (COVID-19) Vaccine Sales Forecast by Region (2025-2030) & (K Units)
Table 157. Global Novel Coronavirus (COVID-19) Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 158. North America Novel Coronavirus (COVID-19) Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 159. North America Novel Coronavirus (COVID-19) Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 160. Europe Novel Coronavirus (COVID-19) Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 161. Europe Novel Coronavirus (COVID-19) Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 162. Asia Pacific Novel Coronavirus (COVID-19) Vaccine Sales Forecast by Region (2025-2030) & (K Units)
Table 163. Asia Pacific Novel Coronavirus (COVID-19) Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 164. South America Novel Coronavirus (COVID-19) Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 165. South America Novel Coronavirus (COVID-19) Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 166. Middle East and Africa Novel Coronavirus (COVID-19) Vaccine Consumption Forecast by Country (2025-2030) & (Units)
Table 167. Middle East and Africa Novel Coronavirus (COVID-19) Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 168. Global Novel Coronavirus (COVID-19) Vaccine Sales Forecast by Type (2025-2030) & (K Units)
Table 169. Global Novel Coronavirus (COVID-19) Vaccine Market Size Forecast by Type (2025-2030) & (M USD)
Table 170. Global Novel Coronavirus (COVID-19) Vaccine Price Forecast by Type (2025-2030) & (USD/Unit)
Table 171. Global Novel Coronavirus (COVID-19) Vaccine Sales (K Units) Forecast by Application (2025-2030)
Table 172. Global Novel Coronavirus (COVID-19) Vaccine Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Novel Coronavirus (COVID-19) Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Novel Coronavirus (COVID-19) Vaccine Market Size (M USD), 2019-2030
Figure 5. Global Novel Coronavirus (COVID-19) Vaccine Market Size (M USD) (2019-2030)
Figure 6. Global Novel Coronavirus (COVID-19) Vaccine Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Novel Coronavirus (COVID-19) Vaccine Market Size by Country (M USD)
Figure 11. Novel Coronavirus (COVID-19) Vaccine Sales Share by Manufacturers in 2023
Figure 12. Global Novel Coronavirus (COVID-19) Vaccine Revenue Share by Manufacturers in 2023
Figure 13. Novel Coronavirus (COVID-19) Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Novel Coronavirus (COVID-19) Vaccine Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Novel Coronavirus (COVID-19) Vaccine Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Novel Coronavirus (COVID-19) Vaccine Market Share by Type
Figure 18. Sales Market Share of Novel Coronavirus (COVID-19) Vaccine by Type (2019-2024)
Figure 19. Sales Market Share of Novel Coronavirus (COVID-19) Vaccine by Type in 2023
Figure 20. Market Size Share of Novel Coronavirus (COVID-19) Vaccine by Type (2019-2024)
Figure 21. Market Size Market Share of Novel Coronavirus (COVID-19) Vaccine by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Novel Coronavirus (COVID-19) Vaccine Market Share by Application
Figure 24. Global Novel Coronavirus (COVID-19) Vaccine Sales Market Share by Application (2019-2024)
Figure 25. Global Novel Coronavirus (COVID-19) Vaccine Sales Market Share by Application in 2023
Figure 26. Global Novel Coronavirus (COVID-19) Vaccine Market Share by Application (2019-2024)
Figure 27. Global Novel Coronavirus (COVID-19) Vaccine Market Share by Application in 2023
Figure 28. Global Novel Coronavirus (COVID-19) Vaccine Sales Growth Rate by Application (2019-2024)
Figure 29. Global Novel Coronavirus (COVID-19) Vaccine Sales Market Share by Region (2019-2024)
Figure 30. North America Novel Coronavirus (COVID-19) Vaccine Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Novel Coronavirus (COVID-19) Vaccine Sales Market Share by Country in 2023
Figure 32. U.S. Novel Coronavirus (COVID-19) Vaccine Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Novel Coronavirus (COVID-19) Vaccine Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Novel Coronavirus (COVID-19) Vaccine Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Novel Coronavirus (COVID-19) Vaccine Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Novel Coronavirus (COVID-19) Vaccine Sales Market Share by Country in 2023
Figure 37. Germany Novel Coronavirus (COVID-19) Vaccine Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Novel Coronavirus (COVID-19) Vaccine Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Novel Coronavirus (COVID-19) Vaccine Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Novel Coronavirus (COVID-19) Vaccine Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Novel Coronavirus (COVID-19) Vaccine Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Novel Coronavirus (COVID-19) Vaccine Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Novel Coronavirus (COVID-19) Vaccine Sales Market Share by Region in 2023
Figure 44. China Novel Coronavirus (COVID-19) Vaccine Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Novel Coronavirus (COVID-19) Vaccine Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Novel Coronavirus (COVID-19) Vaccine Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Novel Coronavirus (COVID-19) Vaccine Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Novel Coronavirus (COVID-19) Vaccine Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Novel Coronavirus (COVID-19) Vaccine Sales and Growth Rate (K Units)
Figure 50. South America Novel Coronavirus (COVID-19) Vaccine Sales Market Share by Country in 2023
Figure 51. Brazil Novel Coronavirus (COVID-19) Vaccine Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Novel Coronavirus (COVID-19) Vaccine Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Novel Coronavirus (COVID-19) Vaccine Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Novel Coronavirus (COVID-19) Vaccine Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Novel Coronavirus (COVID-19) Vaccine Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Novel Coronavirus (COVID-19) Vaccine Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Novel Coronavirus (COVID-19) Vaccine Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Novel Coronavirus (COVID-19) Vaccine Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Novel Coronavirus (COVID-19) Vaccine Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Novel Coronavirus (COVID-19) Vaccine Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Novel Coronavirus (COVID-19) Vaccine Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Novel Coronavirus (COVID-19) Vaccine Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Novel Coronavirus (COVID-19) Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Novel Coronavirus (COVID-19) Vaccine Market Share Forecast by Type (2025-2030)
Figure 65. Global Novel Coronavirus (COVID-19) Vaccine Sales Forecast by Application (2025-2030)
Figure 66. Global Novel Coronavirus (COVID-19) Vaccine Market Share Forecast by Application (2025-2030)
